Fasciolosis

Professor John Dalton graduated from University College Dublin with a PhD in Molecular Parasitology, before becoming a Postdoctoral Research Fellow working on schistosomes at the Johns Hopkins School of Medicine, then malaria at the National Institute of Allergies and Infectious Diseases in Bethesda, USA. He briefly returned to Ireland as a lecturer at Dublin City University, before taking Director level roles at the University of Technology Sydney in Australia, and later McGill University, Canada. Returning home in 2013, he became the Professor in Infectious Diseases at Queens University of Belfast, Northern Ireland, and since 2019 has taken the role of Science Foundation Ireland (SFI) Professor in Molecular Parasitology at the National University of Ireland Galway.

1: The Life Cycle of Fasciola hepatica, S J Andrews, Schering-Plough Animal Health, Uxbridge, UK 2: Development of Fasciola hepatica in the Intermediate Host, T K Graczyk, John Hopkins University, Baltimore, USA and B Fried, Lafayette College, Easton, USA 3: Development of Fasciola hepatica in the Mammalian Host, I Fairweather, The Queen’s University of Belfast, Northern Ireland, et al. 4: Epidemiology and Control, P Torgerson, University College, Dublin, Republic of Ireland, and J Claxton, University of Liverpool, UK 5: Predicting Outbreaks of Fasciolosis: From Ollerenshaw to Satellites, J B Malone, Louisiana State University, USA and J M Yilma, Addis Ababa University, Ethiopia 6: Pathology, Pathophysiology and Clinical Aspects, C A Behm, The Australian National University, Australia and N C Sangster, University of Sydney, Australia 7: Mechanisms of Fasciolicide Action and Drug Resistance in Fasciola hepatica, I Fairweather and J C Boray, Elizabeth Macarthur Agricultural Institute, NSW, Australia 8: Metabolism, A G M Tielens, Utrecht University, The Netherlands 9: Neurobiology, D W Halton, The Queen’s University of Belfast, Northern Ireland, et al. 10: Immunology of Fasciola hepatica Infection, G Mulcahy, University College Dublin, Republic of Ireland, et al. 11: Development of Vaccines Against Fasciola hepatica, T W Spithill, Monash University, Clayton, Australia, et al. 12: Human Fasciolosis, S Mas-Coma, Universidad de Valencia, Spain, et al. 13: Immunodiagnosis of Human and Animal Fasciolosis, G V Hillyer, University of Puerto Rico, Suan Juan, USA 14: Molecular Biology, M Panaccio, Nomura/JAFCO Investments (Asia) Ltd., Melbourne, Australia and A Trudgett, The Queen’s University of Belfast, Northern Ireland 15: Fasciola gigantica: Epidemiology, Control, Immunology and Molecular Biology, T W Spithill, Monash University, Clayton, Australia, et al.